Edx Medical Group (LON:EDX – Get Free Report) insider Christopher Evans acquired 197,500 shares of Edx Medical Group stock in a transaction that occurred on Friday, November 6th. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £15,800.
Edx Medical Group Trading Down 13.5%
Edx Medical Group stock opened at GBX 8 on Thursday. Edx Medical Group has a 12 month low of GBX 6 and a 12 month high of GBX 13. The stock has a fifty day simple moving average of GBX 8.68. The firm has a market capitalization of £34.51 million and a P/E ratio of -5.37.
Edx Medical Group (LON:EDX – Get Free Report) last issued its earnings results on Thursday, September 3rd. The company reported GBX (1.50) earnings per share for the quarter.
Edx Medical Group Company Profile
EDX Medical Group plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients. The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions.
Recommended Stories
- Five stocks we like better than Edx Medical Group
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Edx Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edx Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
